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Response
Epidemiological studies suggest that the consumption of wine, particularly red wine, reduces the incidence of morbidity and mortality from coronary heart disease. As stated by Dr Cheng in his letter, it is conceivable that the unique cardioprotective properties of red wine reside in the multiple actions of flavonoids, among which the antioxidant action is probably the most relevant. Although we agree that resveratrol, one of the flavonoids most studied, is a strong potential candidate to explain the cardioprotection of red wine, it is difficult to determine clearly which antioxidant is responsible for this effect. On the one hand, quercetin and catechin reduce the progression of atherosclerosis in apoE-deficient mice and the susceptibility of LDL to oxidation and aggregation. 1 Catechin and vitamin E also prevent the development of fatty streaks in hypercholesterolemic hamsters. 2 On the other hand, although resveratrol inhibits platelet activation and has antiinflammatory properties, paradoxically, it promotes atherosclerosis in hypercholesterolemic rabbits. 3 The complexity of the issue is further stressed by the absence of an apparent effect of vitamin E on cardiovascular events in high-risk patients, at least during the years of this study. 4 Given the pleiotropic effects of nuclear factor (NF)-B in regulating cell growth/apoptosis and inflammation, some have suggested that it could be implicated in the pathogenesis of cardiovascular disease. In our article, we demonstrated that red wine, but not another form of alcoholic beverage like vodka, prevented NF-B activation in peripheral mononuclear cells during postprandial lipemia in healthy volunteers. During in vitro studies, we also noted that 2 antioxidants present in red wine (quercetin and ␣-tocopherol succinate) attenuated the NF-B activation caused by VLDL. Although, as mentioned in our article, Wadsworth et al 5 reported that resveratrol did not inhibit lipopolysaccharide-induced NF-B activation in murine macrophage cell line RAW 264.7, recent reports show that it suppresses the NF-B activation elicited by tumor necrosis factor-␣ 6 and inhibits inhibitor KB kinase activation.
It is of paramount importance to unravel which components of red wine are implicated in its beneficial cardiovascular effects. In this regard, red wine contains Ϸ60 antioxidants, and it is possible that there could be a certain synergism among some of them. In addition, we could not discard that possibility that red wine alcohol also participates in the beneficial effect by allowing a better absorption of other wine components. 
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